TY - JOUR
T1 - Hyperferritinemia-cataract syndrome: Long-term ophthalmic observations in an Italian family
AU - Cosentino, Ilaria
AU - Zeri, Fabrizio
AU - Swann, Peter G.
AU - Majore, Silvia
AU - Radio, Francesca Clementina
AU - Palumbo, Paolo
AU - Grammatico, Paola
AU - Petitti, Vincenzo
PY - 2016/2/5
Y1 - 2016/2/5
N2 - Background: Hyperferritinemia-cataract syndrome (HCS) is a rare Mendelian condition characterized by bilateral cataract and high levels of serum ferritin in the absence of iron overload.
Methods: HCS was diagnosed in three adult siblings. In two of them it was possible to assess lens changes initially in 1995 and again in 2013. Serum ferritin, iron, transferrin concentrations and transferrin saturation percentage were also measured, and the Iron Responsive Element (IRE) region of the L-ferritin gene (FTL) was studied.
Results: Serum ferritin concentrations were considerably elevated while serum iron, transferrin and transferrin saturation levels were within the normal range in each sibling. Cataract changes in our patients were consistent with those previously reported in the literature. Progression of the cataract, an aspect of few studies in this syndrome, appeared to be quite limited in extent. The heterozygous +32G to T (-168G>T) substitution in the IRE of the FTL gene was detected in this family.
Conclusions: Ophthalmic and biochemical studies together with genetic testing confirmed HCS in three family members. Although the disorder has been extensively described in recent years, little is known regarding cataract evolution over time. In our cases, lens evaluations encompassed many years, identified bilateral cataract of typical morphology and supported the hypothesis that this unique clinical feature of the disease tends to be slowly progressive in nature, at least in adults.
AB - Background: Hyperferritinemia-cataract syndrome (HCS) is a rare Mendelian condition characterized by bilateral cataract and high levels of serum ferritin in the absence of iron overload.
Methods: HCS was diagnosed in three adult siblings. In two of them it was possible to assess lens changes initially in 1995 and again in 2013. Serum ferritin, iron, transferrin concentrations and transferrin saturation percentage were also measured, and the Iron Responsive Element (IRE) region of the L-ferritin gene (FTL) was studied.
Results: Serum ferritin concentrations were considerably elevated while serum iron, transferrin and transferrin saturation levels were within the normal range in each sibling. Cataract changes in our patients were consistent with those previously reported in the literature. Progression of the cataract, an aspect of few studies in this syndrome, appeared to be quite limited in extent. The heterozygous +32G to T (-168G>T) substitution in the IRE of the FTL gene was detected in this family.
Conclusions: Ophthalmic and biochemical studies together with genetic testing confirmed HCS in three family members. Although the disorder has been extensively described in recent years, little is known regarding cataract evolution over time. In our cases, lens evaluations encompassed many years, identified bilateral cataract of typical morphology and supported the hypothesis that this unique clinical feature of the disease tends to be slowly progressive in nature, at least in adults.
KW - Cataract
KW - hyperferritinemia-cataract syndrome
KW - iron responsive element
KW - L-ferritin gene
UR - https://www.tandfonline.com/doi/full/10.3109/13816810.2015.1059460
U2 - 10.3109/13816810.2015.1059460
DO - 10.3109/13816810.2015.1059460
M3 - Article
SN - 1381-6810
VL - 37
SP - 318
EP - 322
JO - Ophthalmic Genetics
JF - Ophthalmic Genetics
IS - 3
ER -